L&K Biomed Ltd.

KOSDAQ:A156100 Stock Report

Market Cap: ₩136.0b

L&K Biomed Valuation

Is A156100 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of A156100 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate A156100's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate A156100's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for A156100?

Key metric: As A156100 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for A156100. This is calculated by dividing A156100's market cap by their current revenue.
What is A156100's PS Ratio?
PS Ratio4.1x
Sales₩33.18b
Market Cap₩135.97b

Price to Sales Ratio vs Peers

How does A156100's PS Ratio compare to its peers?

The above table shows the PS ratio for A156100 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average2.6x
A226400 OSTEONIC
3.1xn/a₩101.0b
A149980 Hironic
3.1xn/a₩108.0b
A048870 Synergy Innovation
2.1xn/a₩202.6b
A036220 Osang HealthcareLtd
2.2xn/a₩162.0b
A156100 L&K Biomed
4.1xn/a₩136.0b

Price-To-Sales vs Peers: A156100 is expensive based on its Price-To-Sales Ratio (4.1x) compared to the peer average (2.6x).

Price to Sales Ratio vs Industry

How does A156100's PS Ratio compare vs other companies in the KR Medical Equipment Industry?

2 CompaniesPrice / SalesEstimated GrowthMarket Cap
A008490 Suheung
0.2x6.9%US$109.23m
A083550 KM
0.3xn/aUS$24.90m
No more companies available in this PS range
A156100 4.1xIndustry Avg. 2.1xNo. of Companies17PS02.44.87.29.612+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: A156100 is expensive based on its Price-To-Sales Ratio (4.1x) compared to the KR Medical Equipment industry average (2.1x).

Price to Sales Ratio vs Fair Ratio

What is A156100's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

A156100 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio4.1x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate A156100's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Vieworks

₩193.3b

Develops, manufactures, and sells imaging systems and solutions.

A100120

₩21,050.00

7D

-2.5%

1Y

-22.8%

Wonbiogen

₩43.8b

Develops and sells medical equipment in South Korea.

A307280

₩1,234.00

7D

-2.2%

1Y

-22.3%

Access Bio

₩194.4b

Engages in the research, development, and manufacture of in vitro rapid diagnostic tests, biosensors, and molecular diagnostic products worldwide.

A950130

₩5,750.00

7D

2.7%

1Y

-34.9%